Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Microbial Cell Factories à la Carte: Elimination of Global Regulators Cra and ArcA Generates Metabolic Backgrounds Suitable for the Synthesis of Bioproducts in Escherichia coli.

Egoburo DE, Diaz Peña R, Alvarez DS, Godoy MS, Mezzina MP, Pettinari MJ.

Appl Environ Microbiol. 2018 Sep 17;84(19). pii: e01337-18. doi: 10.1128/AEM.01337-18. Print 2018 Oct 1.

2.

A New Player in the Biorefineries Field: Phasin PhaP Enhances Tolerance to Solvents and Boosts Ethanol and 1,3-Propanediol Synthesis in Escherichia coli.

Mezzina MP, Álvarez DS, Egoburo DE, Díaz Peña R, Nikel PI, Pettinari MJ.

Appl Environ Microbiol. 2017 Jun 30;83(14). pii: e00662-17. doi: 10.1128/AEM.00662-17. Print 2017 Jul 15.

3.

Editorial (Thematic Issue: Proceedings from the EMBO Workshop: ``Modern DNA Concepts and Tools for Safe Gene Transfer and Modificatio``).

Merten OW, Mezzina M, Fisson S.

Curr Gene Ther. 2016;16(3):153-5. No abstract available.

PMID:
27457888
4.

Phasins, Multifaceted Polyhydroxyalkanoate Granule-Associated Proteins.

Mezzina MP, Pettinari MJ.

Appl Environ Microbiol. 2016 Aug 15;82(17):5060-7. doi: 10.1128/AEM.01161-16. Print 2016 Sep 1. Review.

5.

A phasin with extra talents: a polyhydroxyalkanoate granule-associated protein has chaperone activity.

Mezzina MP, Wetzler DE, de Almeida A, Dinjaski N, Prieto MA, Pettinari MJ.

Environ Microbiol. 2015 May;17(5):1765-76. doi: 10.1111/1462-2920.12636. Epub 2014 Dec 17.

PMID:
25297625
6.

A phasin with many faces: structural insights on PhaP from Azotobacter sp. FA8.

Mezzina MP, Wetzler DE, Catone MV, Bucci H, Di Paola M, Pettinari MJ.

PLoS One. 2014 Jul 31;9(7):e103012. doi: 10.1371/journal.pone.0103012. eCollection 2014.

7.

Escherichia coli redox mutants as microbial cell factories for the synthesis of reduced biochemicals.

Ruiz JA, de Almeida A, Godoy MS, Mezzina MP, Bidart GN, Méndez BS, Pettinari MJ, Nikel PI.

Comput Struct Biotechnol J. 2013 Jan 18;3:e201210019. doi: 10.5936/csbj.201210019. eCollection 2012. Review.

8.

An initiative to manufacture and characterize baculovirus reference material.

Kamen AA, Aucoin MG, Merten OW, Alves P, Hashimoto Y, Airenne K, Hu YC, Mezzina M, van Oers MM.

J Invertebr Pathol. 2011 Jul;107 Suppl:S113-7. doi: 10.1016/j.jip.2011.02.007.

PMID:
21784226
9.

Adeno-associated viruses.

Mezzina M, Merten OW.

Methods Mol Biol. 2011;737:211-34. doi: 10.1007/978-1-61779-095-9_9.

PMID:
21590399
10.

Gene therapy bio-safety: scientific and regulatory issues.

Gonin P, Buchholz CJ, Pallardy M, Mezzina M.

Gene Ther. 2005 Oct;12 Suppl 1:S146-52.

PMID:
16231047
12.

Assessment of optimal transduction of primary human skin keratinocytes by viral vectors.

Gagnoux-Palacios L, Hervouet C, Spirito F, Roques S, Mezzina M, Danos O, Meneguzzi G.

J Gene Med. 2005 Sep;7(9):1178-86.

PMID:
15880606
13.

Treatment of peripheral sensorineural hearing loss: gene therapy.

Duan M, Venail F, Spencer N, Mezzina M.

Gene Ther. 2004 Oct;11 Suppl 1:S51-6. Review.

PMID:
15454957
14.

Gene therapy for rheumatoid arthritis.

Bessis N, Doucet C, Cottard V, Douar AM, Firat H, Jorgensen C, Mezzina M, Boissier MC.

J Gene Med. 2002 Nov-Dec;4(6):581-91. Review.

PMID:
12439850
15.

Adenoviral and adeno-associated viral vector mediated gene transfer in the guinea pig cochlea.

Li Duan M, Bordet T, Mezzina M, Kahn A, Ulfendahl M.

Neuroreport. 2002 Jul 19;13(10):1295-9.

PMID:
12151790
16.
17.

Characterization of the mtTFA gene and identification of a processed pseudogene in rat.

Mezzina M, Reyes A, D'Errico I, Gadaleta G.

Gene. 2002 Mar 6;286(1):105-12.

PMID:
11943465
18.

First meeting of the Gene Vector Production network, 4-5 October 2001, Evry, France.

Mezzina M; Scientific Committee.

J Gene Med. 2002 Jan-Feb;4(1):105-8. No abstract available.

PMID:
11865811
19.

Five years of vector service for gene therapy.

Mezzina M, Danos O.

Trends Genet. 2002 Mar;18(3):118-9. Review. No abstract available.

PMID:
11858829
20.

A common exocytotic mechanism mediates axonal and dendritic outgrowth.

Martinez-Arca S, Coco S, Mainguy G, Schenk U, Alberts P, Bouillé P, Mezzina M, Prochiantz A, Matteoli M, Louvard D, Galli T.

J Neurosci. 2001 Jun 1;21(11):3830-8.

21.

Cutaneous gene transfer and therapy: the present and the future.

Spirito F, Meneguzzi G, Danos O, Mezzina M.

J Gene Med. 2001 Jan-Feb;3(1):21-31. Review.

PMID:
11269332
22.
23.

Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis.

Cottard V, Mulleman D, Bouille P, Mezzina M, Boissier MC, Bessis N.

Gene Ther. 2000 Nov;7(22):1930-9.

25.

Novel complementation assays for DNA repair-deficient cells. Transient and stable expression of DNA repair genes.

Zeng L, Sarasin A, Mezzina M.

Methods Mol Biol. 1999;113:87-100. No abstract available.

PMID:
10443413
26.

[Cockayne syndrome in Lebanon. Description of 3 cases and review of the literature].

Jabre P, Mezzina M, Megarbane A.

J Med Liban. 1999 Mar-Apr;47(2):144-7. Review. French.

PMID:
10410472
27.

The relative expression of mutated XPB genes results in xeroderma pigmentosum/Cockayne's syndrome or trichothiodystrophy cellular phenotypes.

Riou L, Zeng L, Chevallier-Lagente O, Stary A, Nikaido O, Taïeb A, Weeda G, Mezzina M, Sarasin A.

Hum Mol Genet. 1999 Jun;8(6):1125-33.

PMID:
10332046
28.

Recovery of the normal p53 response after UV treatment in DNA repair-deficient fibroblasts by retroviral-mediated correction with the XPD gene.

Dumaz N, Drougard C, Quilliet X, Mezzina M, Sarasin A, Daya-Grosjean L.

Carcinogenesis. 1998 Sep;19(9):1701-4.

PMID:
9771945
29.

The nuclear concentration of kin17, a mouse protein that binds to curved DNA, increases during cell proliferation and after UV irradiation.

Kannouche P, Pinon-Lataillade G, Tissier A, Chevalier-Lagente O, Sarasin A, Mezzina M, Angulo JF.

Carcinogenesis. 1998 May;19(5):781-9.

PMID:
9635863
30.

Retrovirus-mediated DNA repair gene transfer into xeroderma pigmentosum cells: perspectives for a gene therapy.

Zeng L, Sarasin A, Mezzina M.

Cell Biol Toxicol. 1998 Mar;14(2):105-10.

PMID:
9553721
31.

Retroviral-mediated correction of DNA repair defect in xeroderma pigmentosum cells is associated with recovery of catalase activity.

Quilliet X, Chevallier-Lagente O, Zeng L, Calvayrac R, Mezzina M, Sarasin A, Vuillaume M.

Mutat Res. 1997 Dec;385(3):235-42.

PMID:
9506892
32.

Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.

Zeng L, Quilliet X, Chevallier-Lagente O, Eveno E, Sarasin A, Mezzina M.

Gene Ther. 1997 Oct;4(10):1077-84.

33.

Neurological manifestations in two related xeroderma pigmentosum group D patients: complications of the late-onset type of the juvenile form.

Stojkovic T, Defebvre L, Quilliet X, Eveno E, Sarasin A, Mezzina M, Destée A.

Mov Disord. 1997 Jul;12(4):616-9. No abstract available.

PMID:
9251090
34.

Photocarcinogenesis and inhibition of intercellular adhesion molecule 1 expression in cells of DNA-repair-defective individuals.

Ahrens C, Grewe M, Berneburg M, Grether-Beck S, Quilliet X, Mezzina M, Sarasin A, Lehmann AR, Arlett CF, Krutmann J.

Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6837-41.

35.

A mutation in the XPB/ERCC3 DNA repair transcription gene, associated with trichothiodystrophy.

Weeda G, Eveno E, Donker I, Vermeulen W, Chevallier-Lagente O, Taïeb A, Stary A, Hoeijmakers JH, Mezzina M, Sarasin A.

Am J Hum Genet. 1997 Feb;60(2):320-9.

36.

Long-term complementation of DNA repair deficient human primary fibroblasts by retroviral transduction of the XPD gene.

Quilliet X, Chevallier-Lagente O, Eveno E, Stojkovic T, Destée A, Sarasin A, Mezzina M.

Mutat Res. 1996 Dec 2;364(3):161-9.

PMID:
8960128
37.

The alkylating antitumor drug tallimustine does not induce DNA repair.

Rossi R, Montecucco A, Capolongo L, Mezzina M, Chevallier-Lagente O, Sarasin A, Ciarrocchi G.

Anticancer Res. 1996 Nov-Dec;16(6B):3779-83.

PMID:
9042257
38.

Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.

Carreau M, Quilliet X, Eveno E, Salvetti A, Danos O, Heard JM, Mezzina M, Sarasin A.

Hum Gene Ther. 1995 Oct;6(10):1307-15.

PMID:
8590735
39.

Correction by the ERCC2 gene of UV sensitivity and repair deficiency phenotype in a subset of trichothiodystrophy cells.

Mezzina M, Eveno E, Chevallier-Lagente O, Benoit A, Carreau M, Vermeulen W, Hoeijmakers JH, Stefanini M, Lehmann AR, Weber CA, et al.

Carcinogenesis. 1994 Aug;15(8):1493-8.

PMID:
8055625
40.

The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor.

Schaeffer L, Moncollin V, Roy R, Staub A, Mezzina M, Sarasin A, Weeda G, Hoeijmakers JH, Egly JM.

EMBO J. 1994 May 15;13(10):2388-92.

41.

A new nucleotide-excision-repair gene associated with the disorder trichothiodystrophy.

Stefanini M, Vermeulen W, Weeda G, Giliani S, Nardo T, Mezzina M, Sarasin A, Harper JI, Arlett CF, Hoeijmakers JH, et al.

Am J Hum Genet. 1993 Oct;53(4):817-21.

42.

Characterization of the DNA double strand break repair defect in scid mice.

Chang C, Biedermann KA, Mezzina M, Brown JM.

Cancer Res. 1993 Mar 15;53(6):1244-8.

43.

Purification and characterization of a mitochondrial endonuclease from Drosophila melanogaster embryos.

Harosh I, Mezzina M, Harris PV, Boyd JB.

Eur J Biochem. 1992 Dec 1;210(2):455-60.

44.

Mechanism of action of deoxyribonuclease II from human lymphoblasts.

Harosh I, Binninger DM, Harris PV, Mezzina M, Boyd JB.

Eur J Biochem. 1991 Dec 5;202(2):479-84.

45.

DNA ligase activity in human cell lines from normal donors and Bloom's syndrome patients.

Mezzina M, Nardelli J, Nocentini S, Remault G, Sarasin A.

Nucleic Acids Res. 1989 Apr 25;17(8):3091-106.

46.

Enhanced deoxyribonuclease activity in human transformed cells and in Bloom's syndrome cells.

Mezzina M, Nocentini S, Nardelli J, Renault G, Moustacchi E, Sarasin A.

Mol Carcinog. 1989;2(4):179-83.

PMID:
2803519
47.
48.

N-acetoxy-N-2-acetylaminofluorene-induced damage on SV40 DNA: inhibition of DNA replication and visualization of DNA lesions.

Armier J, Mezzina M, Leng M, Fuchs RP, Sarasin A.

Carcinogenesis. 1988 May;9(5):789-95.

PMID:
2835192
49.

Mammalian DNA ligase. Structure and function in rat-liver tissues.

Mezzina M, Rossignol JM, Philippe M, Izzo R, Bertazzoni U, Sarasin A.

Eur J Biochem. 1987 Jan 15;162(2):325-32.

50.

Variation in DNA ligase structure during repair and replication processes in monkey kidney cells.

Mezzina M, Franchi E, Izzo R, Bertazzoni U, Rossignol JM, Sarasin A.

Biochem Biophys Res Commun. 1985 Nov 15;132(3):857-63.

PMID:
3935108

Supplemental Content

Loading ...
Support Center